Advances in CRISPR/Cas technology have revolutionized genome editing, offering unprecedented precision and efficiency in modifying genetic material. In our book, "Optimization of CRISPR/Cas Editing Efficiency in Non-Model Organisms," I explored the complexities of utilizing this powerful tool in research involving non-model organisms. From understanding the molecular machinery of the CRISPR/Cas system to overcoming barriers in delivery and enhancing homology-directed repair efficiency, each chapter offers a comprehensive exploration of key concepts and strategies. Additionally, I addressed the ethical and regulatory considerations inherent in genome editing, providing insights into the evolving regulatory landscape governing the use of CRISPR/Cas technology. Through evidence-based discussions and case studies, this book aims to guide researchers and policymakers in navigating the intricacies of CRISPR/Cas editing in non-model organisms, ultimately fostering responsible and impactful research practices.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Vendeur : PBShop.store UK, Fairford, GLOS, Royaume-Uni
PAP. Etat : New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. N° de réf. du vendeur L0-9798320215464
Quantité disponible : Plus de 20 disponibles
Vendeur : Rarewaves.com USA, London, LONDO, Royaume-Uni
Paperback. Etat : New. N° de réf. du vendeur LU-9798320215464
Quantité disponible : Plus de 20 disponibles
Vendeur : CitiRetail, Stevenage, Royaume-Uni
Paperback. Etat : new. Paperback. Advances in CRISPR/Cas technology have revolutionized genome editing, offering unprecedented precision and efficiency in modifying genetic material. In our book, "Optimization of CRISPR/Cas Editing Efficiency in Non-Model Organisms," I explored the complexities of utilizing this powerful tool in research involving non-model organisms. From understanding the molecular machinery of the CRISPR/Cas system to overcoming barriers in delivery and enhancing homology-directed repair efficiency, each chapter offers a comprehensive exploration of key concepts and strategies. Additionally, I addressed the ethical and regulatory considerations inherent in genome editing, providing insights into the evolving regulatory landscape governing the use of CRISPR/Cas technology. Through evidence-based discussions and case studies, this book aims to guide researchers and policymakers in navigating the intricacies of CRISPR/Cas editing in non-model organisms, ultimately fostering responsible and impactful research practices. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. N° de réf. du vendeur 9798320215464
Quantité disponible : 1 disponible(s)
Vendeur : Rarewaves.com UK, London, Royaume-Uni
Paperback. Etat : New. N° de réf. du vendeur LU-9798320215464
Quantité disponible : Plus de 20 disponibles